Acquisition
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
PCI Pharma Services
PR-04-25-NI-05Apr 24, 2025
Clinical Trials
One of Our First Looks at the Burgeoning Australia Biotech Ecosystem
PCI Pharma Services
PAO-10-24-RTM-04Nov 04, 2024
Clinical Trials
PCI Pharma Services Wins Supply Chain Excellence Award for Digital Platform to Manage Clinical Trials and Commercial Lifespans
PCI Pharma Services
PR-10-24-NI-68Oct 30, 2024
CDMO
PCI Invests Over $365 Million in Facilities for Supply of Advanced Drug Delivery and Drug-Device Combination Products
PCI Pharma Services
PR-09-24-NI-15Sep 24, 2024
Digitalization
How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?
Pharma's Almanac
PAO-06-24-RT-02Jun 24, 2024
Investment
What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?
Pharma's Almanac
PAO-06-24-RT-01Jun 24, 2024
Sterile Fill-Finish
PCI Pharma Services Begins Installation of Sterile Fill-Finish and Lyophilization Line as Part of $100 Million New Facility Expansion
PCI Pharma Services
PR-M05-24-01May 02, 2024
ESG
Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report
PCI Pharma Services
PR-M03-24-04Mar 27, 2024
Commitment to ESG Principles
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
Pharma's Almanac
PAO-03-24-CL-03Mar 08, 2024
Robotic Sterile Fill-Finish
Reducing Time to First-in-Human Trials with Robotic Sterile Fill-Finish Manufacturing Services
Peter Kim; Jerome Detreille; Derek Truninger
PAO-02-24-CL-03Feb 14, 2024
Roundtable: Artificial Intelligence
In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?
Pharma's Almanac
PAO-07-23-RT-01Jul 21, 2023
Roundtable: Patient Centricity
How is an increased focus on patient-centric concerns influencing the way that you work?
Pharma's Almanac
PAO-07-23-RT-02Jul 21, 2023
International Markets
In what international markets do you anticipate significant developments in the near future?
Pharma's Almanac
PAO-01-23-RT-02Jan 31, 2023
Disruptive Technology
What do you view as the most disruptive or transformational technology or development on the horizon?
Pharma's Almanac
PAO-01-23-RT-01Jan 31, 2023
Controlled Substances in Clinical Trials
Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand
Rich Nelson; John Hufnagel; Rachel Castro
PCI Pharma Services
PAO-01-23-CL-03Jan 30, 2023
Robotic Sterile Fill-Finish
Accelerating Drug Development Using Robotic Sterile Fill-Finish Platforms
Jeff Clement; Mark Shepanski
PCI Pharma Services
PAO-10-022-CL-09Nov 11, 2022
Future of the Industry
What key indicators do you look at to predict the future of this industry?
Pharma's Almanac
PAO-10-022--RT-02Oct 11, 2022
Sustainability
What is your plan to build a more sustainable business practice in the coming years?
Pharma's Almanac
PAO-10-022--RT-01Oct 11, 2022
Unmet Needs
In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?
Pharma's Almanac
PAO-06-022--RT-01Jun 24, 2022
Industry Challenges
What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
Pharma's Almanac
O-06-022--RT-01Jun 24, 2022